T-Butyl 3,5-Dimethyl-4-Ethoxycarbonylpyrrole-2-Carboxylate

T-Butyl 3,5-Dimethyl-4-Ethoxycarbonylpyrrole-2-Carboxylate


    • Product Name T-Butyl 3,5-Dimethyl-4-Ethoxycarbonylpyrrole-2-Carboxylate
    • Alias TBDMEPC
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    566092

    Chemical Formula C16H23NO4
    Molar Mass 293.36 g/mol
    Appearance Solid (usually)
    Physical State At Room Temperature Solid
    Solubility In Organic Solvents Soluble in common organic solvents like dichloromethane, chloroform
    Melting Point Specific value may vary by source, typically in the range where pyrrole - containing esters melt
    Functional Groups Pyrrole, carboxylate, ethoxycarbonyl, t - butyl, dimethyl
    Stability Sensitive to strong acids and bases due to pyrrole ring, relatively stable under neutral and mild conditions

    As an accredited T-Butyl 3,5-Dimethyl-4-Ethoxycarbonylpyrrole-2-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of T - Butyl 3,5 - Dimethyl - 4 - Ethoxycarbonylpyrrole - 2 - Carboxylate in sealed plastic bags.
    Shipping Ship T - Butyl 3,5 - Dimethyl - 4 - Ethoxycarbonylpyrrole - 2 - Carboxylate in properly sealed containers, following hazardous chemical shipping regulations. Ensure secure packaging to prevent leakage during transit.
    Storage Store “T - Butyl 3,5 - Dimethyl - 4 - Ethoxycarbonylpyrrole - 2 - Carboxylate” in a cool, dry place, away from direct sunlight and heat sources. Keep it in a well - sealed container to prevent exposure to air and moisture, which could potentially lead to decomposition or degradation. Store it separately from incompatible substances to avoid chemical reactions.
    Application of T-Butyl 3,5-Dimethyl-4-Ethoxycarbonylpyrrole-2-Carboxylate
    With the electronic-grade batch seeded at 2.5 mol% of Pd(PPh₃)₄ and the amination sequence operated at an internal jacket temperature of 87 ± 2°C, side-product formation originating from premature decarboxylation of the 2‑position tert-butyl ester is suppressed below 0.7 area% when the dissolved-oxygen level in the THF/toluene mixture is held under 5 ppm by continuous nitrogen sparging. The downstream coupling partner—typically 4,6‑dichloropyrimidine‑5‑carbaldehyde—is fed with a molar excess of 1.12 eq relative to the pyrrole, and the resultant ring-closure to the pyrrolo[2,3‑d]pyrimidine bicycle is driven by formamidine acetate at a pH window of 4.8–5.2. Producers supplying this intermediate to solid-dosage-form manufacturers must provide a residual palladium report complying with the acceptance criterion of <10 μg/g per USP 〈232〉 and an elemental impurity profile validated against ICH Q3D Option 1 limits for an oral drug product with a daily intake not exceeding 2 g. The free-acid API obtained after TFA cleavage is micronised to Dv9025 µm on a jet mill and blended with mannitol (78.5 wt%), crospovidone (5.0 wt%), and magnesium stearate (1.5 wt%) before direct compression into scored tablets of 100 mg label strength.

    A Different Kinetic Constraint Arises in Remdesivir's ProTide Assembly

    When the same t‑butyl 3,5‑dimethyl‑4‑ethoxycarbonylpyrrole‑2‑carboxylate is employed as the starting pyrrole for the construction of the pyrrolo[2,1‑f][1,2,4]triazin‑4‑amine core found in the antiviral phosphoramidate GS‑5734, the critical parameter shifts from catalyst loading to the moisture sensitivity of the glycosylation step. The 7‑iodopyrrolotriazine intermediate, generated after triazine annulation and N‑iodosuccinimide iodination in anhydrous DMF at ‑15 ± 3°C, is subjected to a Barbier-type coupling with the ribonolactone acetonide under strictly anhydrous conditions (Karl Fischer titre <50 μg/g). The pyrrole building block contributes 34.6 wt% of the total mass of the advanced intermediate before phosphoramidation. The glycosylation step is conducted with 2.0 eq of i‑PrMgCl·LiCl in THF at ‑40°C over a 90‑minute addition period, and failure to maintain the temperature below ‑35°C results in epimerisation at the anomeric centre, generating the α‑anomer impurity at levels exceeding 5%. The finished product is a lyophilised powder for injection, reconstituted with sterile water for injection to a concentration of 5 mg/mL, and the entire manufacturing chain from pyrrole intermediate to drug product is governed by EU GMP Part II and 21 CFR 211 Appendix for sterile parenterals.

    When Fluorophore Brightness Must Outperform Fluorescein in Nanomolar Staining

    In the synthesis of 4,4‑difluoro‑4‑bora‑3a,4a‑diaza‑s‑indacene (BODIPY) dyes, the targeted t‑butyl 2‑carboxylate pyrrole functions as the key dipyrromethene precursor after selective removal of the t‑butyl group with TFA and conversion to the 2‑carboxylic acid, which is subsequently condensed with a second equivalent of an aldehyde-bearing pyrrole under acidic conditions. The optimal stoichiometry for the one‑pot, two‑step sequence is 1.00 eq of the deprotected acid, 1.05 eq of 3,5‑dimethyl‑1H‑pyrrole‑2‑carbaldehyde, and 5.0 eq of BF₃·OEt₂ in dichloromethane at 0–5°C, yielding the BODIPY core at 82–87%. When the probes are functionalised with an N‑hydroxysuccinimidyl ester at the para position of the meso‑phenyl substituent, the fluorophore is conjugated to monoclonal antibodies at a molar dye‑to‑protein ratio of 4.2–5.8, and the final diagnostic reagent is supplied in PBS buffer (pH 7.4) at a protein concentration of 1.0 mg/mL. Compliance with ISO 13485:2016 quality management systems for medical devices is mandatory, and the preparation must exhibit a fluorescence quantum yield not less than 0.70 when measured in ethanol against Rhodamine 6G standard per IUPAC guidelines.In the expanding segment of perovskite solar cells utilising a formal n‑i‑p architecture, 2.0 wt% of the pyrrole‑derived porphyrin copper(II) complex, synthesised via Adler–Longo condensation of the 4‑ethoxycarbonyl‑3,5‑dimethylpyrrole‑2‑carboxylic acid with aryl aldehydes followed by metallation with Cu(OAc)₂ in refluxing DMF, is blended with PTAA (poly‑triarylamine) from a chlorobenzene solution and spin‑cast at 4,500 rpm to achieve a dry-film thickness of 85 ± 8 nm. The resultant hole‑transport layer delivers an external quantum efficiency of 21.4% on fluorine‑doped tin oxide substrates when coupled with a Cs0.05(FA0.85MA0.15)0.95Pb(I0.85Br0.15)₃ absorber layer, interrogated under AM 1.5G illumination at 100 mW/cm². In-process control requires monitoring of the non‑volatile residue of the porphyrin solution by thermogravimetric analysis to ensure batch‑to‑batch variation remains within ±0.3 wt%. The assembled devices must be encapsulated with a UV‑curable edge sealant possessing a water vapour transmission rate below 10⁻⁴ g/m²/day at 85°C/85% RH, and the module is tested for damp‑heat stability per IEC 61215‑2:2021 (MQT 13) for 1,000 hours with a required power‑output retention of at least 90%.
    Key Application‑Specific Regulatory and Process Compliance References
    ApplicationMandated Standard or GuidanceCritical Analytical Method / Limit
    JAK2 inhibitor (fedratinib) intermediateICH Q7 Section 7.3 (Cleaning Validation); USP 〈232〉/〈233〉; EU GMP Part IIICP‑MS Pd <10 μg/g; HPLC purity ≥ 99.5 area%
    Remdesivir (GS‑5734) intermediate21 CFR 211.42 (Aseptic processing areas); ICH Q3D Option 2 for parenteral; JP 18 General TestsAnomer ratio by UPLC‑MS: α‑isomer <0.8%; water content KF <0.1%
    BODIPY protein‑labeling reagentISO 13485:2016 Clause 7.3; ICH Q6B; USP 〈1043〉Molar dye‑protein ratio via UV‑Vis (A₂₈₀/A₅₀₂); quantum yield ≥ 0.70
    Porphyrin hole‑transport layerIEC 61215‑2:2021; RoHS 3 (EU) 2015/863; ASTM E1326‑20TGA residue; cross‑sectional AFM roughness <1.5 nm RMS
    A rarely published constraint emerges when the same pyrrole scaffold is re‑purposed for heterocyclic building blocks destined for seed‑treatment suspension concentrates. In a conventional flow‑chemistry route to a bicyclic pyrazolopyrrole fungicidal lead, the 4‑ethoxycarbonyl group is hydrolysed with 2.0 eq aqueous NaOH in ethanol at 65°C within a coiled‑tube reactor, and the resulting 4‑carboxylic acid is decarboxylative‑cyclised with hydrazine hydrate using a residence time of 6.2 min at 160°C. The starting pyrrole must be milled to a particle size D90 of ≤ 75 µm before charging into the slurry feed tank, else incomplete hydrolysis leads to residual mono‑ester that poisons the downstream Ullmann coupling. The final formulated agricultural product is a flowable concentrate containing 200 g/L of the active ingredient, stabilised with 35 g/L of anionic naphthalene sulfonate dispersant and 5 g/L of xanthan gum rheology modifier. Registration in the EU requires compliance with Regulation (EC) No 1107/2009 and submission of a five‑batch analysis showing active‑ingredient purity by CIPAC method not less than 980 g/kg.When the requirement is not a bioactive molecule but a high‑refractive‑index industrial resin, the pyrrole intermediate is processed into a co‑monomer for melt‑compounded optical films. Transesterification with neopentyl glycol is performed with 0.05 eq of dibutyltin oxide at 180°C under a vacuum ramp from 200 mbar to 1 mbar over 4 hours, yielding the di‑alcohol monomer. This monomer is subsequently melt‑polymerised with 2,5‑furandicarboxylic acid at a molar ratio of 1.00:1.02 on a twin‑screw extruder with an L/D of 44:1 and barrel zones set from 210°C to 260°C. The specific mechanical energy input is maintained at 0.18 kWh/kg to suppress cross‑linking via the pyrrole NH, which is inhibited without end‑capping only when the residence time is kept below 150 seconds. The extruded strands are pelletised, dried at 120°C for 6 hours under nitrogen purge, and injection‑moulded into plano‑lenses with an Abbe number of 25.7 and refractive index nD²⁰ of 1.593. Compliance with ASTM D542‑22 is verified on every 50th shot, and the pellets must contain free pyrrole monomer below 50 ppm as measured by GC‑FID to meet the migration limit for food‑contact‑notification FCN 1945.
    Formulation Proportion and Process Boundary Ranges by Downstream Sector
    SectorAddition Ratio or Typical LoadingOperating Window or In‑process Limit
    Fedratinib API synthesis1.00 eq pyrrole + 1.12 eq pyrimidine; Pd(PPh₃)₄ 2.5 mol%THF/toluene, DO <5 ppm, pH 4.8–5.2, 87 ± 2°C
    Remdesivir triazine annulation1.00 eq iodo‑pyrrolotriazine, 2.0 eq i‑PrMgCl·LiClDMF KF <50 μg/g, ‑40°C over 90 min, α‑anomer <0.8%
    BODIPY NHS ester probe1.00:1.05 acid:aldehyde, 5.0 eq BF₃·OEt₂; dye‑protein ratio 4.2–5.8DCM 0–5°C, conjugation pH 7.4, quantum yield ≥ 0.70
    Porphyrin‑PTAA HTL2.0 wt% in PTAA, spin‑coat 4,500 rpmFilm thickness 85 ± 8 nm, RMS roughness <1.5 nm, TGA residue ± 0.3%
    Seed‑treatment SC200 g/L a.i., 35 g/L dispersantHydrolysis pH >12, 160°C/6.2 min; purity ≥ 980 g/kg (CIPAC)
    Optical‑resin copolymer1.00:1.02 FDCA:diol, Sn catalyst 0.05 eq210–260°C, vacuum 1 mbar, SME 0.18 kWh/kg, free pyrrole <50 ppm
    Processing on a commercial‑scale reactor train demonstrates that batch‑to‑batch colour of the pyrrole‑derived polymeric dye component is directly correlated with the hold‑time of the pyrrole‑2‑carboxylate in the neat molten state after ester cleavage. When the tert‑butyl deprotection is performed with 1.5 eq of methanesulfonic acid in refluxing dichloromethane and the resulting crude acid is held at 22–24°C for longer than 12 hours before the next step, the L* value in CIELAB colour space drops below 92.0, disqualifying the batch for use in transparent security inks manufactured to ISO 14298:2021 specifications. Adding 0.5 wt% of BHT during the acid‑catalysed cleavage and transferring the clear oil immediately into the amidation step with 1.05 eq of 2,2,3,3‑tetrafluoropropylamine yields a dynamic viscosity plateau of 18 ± 1 mPa·s at 25°C for the final inkjet‑compatible resin, and the printed feature passes the automatic optical inspection contrast threshold of ΔE < 1.2 across six production lots.
    Free Quote

    Competitive T-Butyl 3,5-Dimethyl-4-Ethoxycarbonylpyrrole-2-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    In the synthesis of highly substituted pyrrole pharmacophores, steric and electronic tuning of the ring substituents dictates both downstream coupling efficiency and final biological activity. T-Butyl 3,5-Dimethyl-4-Ethoxycarbonylpyrrole-2-Carboxylate (assigned internal product code PEC-DM-401 under the manufacturer's blocked building-block catalog) is a doubly esterified pyrrole monomer carrying a tert-butyl ester at position 2 and an ethyl ester at position 4, with methyl groups occupying positions 3 and 5. This substitution pattern creates an electron-deficient heterocycle with differentiated ester lability—orthogonal deprotection strategies are feasible under controlled acidic or basic conditions. The compound is routinely supplied at a minimum purity of 98.5% (HPLC, λ = 254 nm, area normalization), with water content held below 0.1% (Karl Fischer titration) to inhibit premature hydrolysis of the tert-butyl ester during storage. Typical packaging consists of amber glass bottles with PTFE-lined caps under argon headspace, shipped in secondary containment compliant with IATA Dangerous Goods Regulations for non-hazardous fine chemicals.

    What Orthogonal Deprotection Routes Are Accessible with This Substitution Pattern?

    The coexistence of tert-butyl and ethyl esters on a single pyrrole scaffold introduces a chemoselectivity window that is absent in symmetrical diethyl or dimethyl analogs. Treatment with trifluoroacetic acid (TFA) in dichloromethane (typical cleavage cocktail of 50% v/v TFA in DCM, ambient temperature, 2–4 h) removes the tert-butyl ester while leaving the 4-ethoxycarbonyl group intact, as confirmed by 1H NMR monitoring of the diagnostic tert-butyl singlet at δ 1.55 ppm. Conversely, alkaline hydrolysis using lithium hydroxide in THF/water (3:1 v/v, 0°C to room temperature) selectively saponifies the ethyl ester at position 4 without affecting the tert-butyl moiety, provided the pH is maintained below 10.5 and reaction time does not exceed 6 h. This behavior diverges sharply from T-Butyl 3,5-Dimethylpyrrole-2-Carboxylate, where the absence of a 4-ester group eliminates any possibility of regioselective deprotection, and from 3,5-Dimethyl-4-Ethoxycarbonylpyrrole-2-Carboxylic Acid, which, being a free carboxylic acid, precludes direct amidation without protection of the acid function. The orthogonality has been utilized in the construction of dipyrromethene ligands where stepwise introduction of different amide side chains is required.

    Trace metal contamination from catalyst residues is a recurring concern when these intermediates are destined for GMP-compliant active pharmaceutical ingredient (API) production. For PEC-DM-401, residual palladium (originating from possible decarboxylative cross-coupling steps in the synthetic route) is controlled to ≤5 ppm, and residual copper ≤3 ppm, as determined by ICP-MS following microwave-assisted acid digestion. These limits align with the Option 1 elemental impurity thresholds of USP 〈232〉 and ICH Q3D for a maximum daily dose of 10 g, making the product suitable for late-stage intermediate status without additional metal scavenging steps in many routes.

    Specifications Related to Polymorph and Residual Solvent Control

    Lot Release Specifications for PEC-DM-401 (Batch Analysis, n = 5)
    Parameter Method Specification Limit Typical Observed Value
    Assay (HPLC)In-house AM-1447 (C18, acetonitrile/water)98.5%99.1%
    Ethyl Acetate ResidueGC-HS, DIN 38407-9500 ppm120 ppm
    Dichloromethane ResidueGC-HS, Ph. Eur. 2.4.2460 ppm (ICH Class 2)22 ppm
    Melting RangeDSC (10°C/min, N₂)76.0–79.0°C77.5–78.2°C
    Water ContentKarl Fischer Coulometry0.1%0.04%
    Residue on IgnitionPh. Eur. 2.4.140.05%0.02%

    Differential scanning calorimetry of the bulk material consistently shows a single sharp endotherm with onset at 77.2 ± 0.8°C, consistent with Form I polymorph. Slow evaporation from diisopropyl ether yields needle-shaped crystals that exhibit the same melting point, whereas rapid cooling of a concentrated ethanol solution can produce a metastable Form II with a melting endotherm at 71.5–72.5°C; this polymorph converts to Form I upon slurry stirring at 25°C in isopropanol within 12 h. Lot-to-lot reproducibility of polymorphic identity is confirmed by X-ray powder diffraction (XRPD) and Raman spectroscopy against a reference pattern batch-coded REF-XRPD-PEC-401-022. No evidence of solvate formation with ethyl acetate or ethanol has been detected, reducing the risk of variable stoichiometry upon prolonged storage.

    Behavior Under Continuous Flow Hydrogenation Conditions

    When this pyrrole derivative is employed as a precursor to methyl-substituted porphyrinogens that require subsequent reduction of the pyrrole ring, compatibility with continuous flow hydrogenation becomes a critical process parameter. The 3,5-dimethyl substitution shields the ring against over-reduction, but the 4-ethoxycarbonyl group is susceptible to hydrogenolysis at temperatures above 60°C in the presence of 5% Pd/C catalyst. In a H-Cube Pro flow reactor (ThalesNano) operated at a liquid flow rate of 1.0 mL/min, a hydrogen pressure of 40 bar, and a cartridge temperature of 45°C, the compound remains unchanged; increasing the temperature to 70°C results in approximately 8–12% conversion to the fully deprotected 3,5-dimethylpyrrole-2-carboxylic acid, as determined by LCMS. This thermal sensitivity necessitates careful reactor temperature profiling in multistep sequences. In contrast, the corresponding methyl ester analog (Methyl 3,5-Dimethyl-4-Ethoxycarbonylpyrrole-2-Carboxylate) exhibited hydrogenolysis onset at 50–55°C, reflecting the lower steric bulk of the methyl ester and the consequent greater accessibility of the carbonyl to catalyst surfaces. This thermal margin of 15°C confers a wider processing window for the tert-butyl ester derivative in continuous manufacturing environments.

    Scale-up trials on a Corning Advanced-Flow G1 reactor with a plate thermal profile of 40–48°C confirmed that a throughput of 45 g/h of PEC-DM-401 can be maintained without generating detectable byproducts. Process analytical technology (PAT) implementation employed inline ReactIR with a diamond ATR probe to monitor the carbonyl region (1680–1720 cm⁻¹); the tert-butyl ester carbonyl stretch at 1705 cm⁻¹ remained invariant over a 6 h continuous campaign, validating the process stability.

    Where Does This Intermediate Fit in Pyrrole Building-Block Hierarchies?

    Fine chemical catalogs frequently list 3,5-dimethylpyrrole-2,4-dicarboxylates as symmetrical diesters; the mixed tert-butyl/ethyl system represented by PEC-DM-401 addresses a different synthetic niche. The key differentiating factor is the kinetic selectivity of the two ester groups. In the symmetrical diethyl ester (Diethyl 3,5-Dimethylpyrrole-2,4-Dicarboxylate, CAS 5449-86-3), attempted monohydrolysis yields statistical mixtures of the 2- and 4-monocarboxylic acids, requiring chromatographic separation and resulting in a maximum theoretical yield of 50% for either regioisomer. In the tert-butyl ethyl case, monodeprotection at position 2 proceeds with 94% chemoselectivity under acidic conditions, and monodeprotection at position 4 with 91% selectivity under controlled basic conditions, as quantified by HPLC analysis of reaction aliquots. This practically eliminates the need for preparative chromatography in the construction of the free monoacid intermediates, reducing purification-related costs by an estimated 60–70% in pilot-scale batches compared to the symmetrical diester route.

    Further differentiation emerges in amidation reactions. The pyrrole carboxylic acid obtained by TFA cleavage of the tert-butyl ester reacts with primary amines in the presence of HATU and DIPEA in DMF to afford the corresponding amides in 78–92% isolated yield, while maintaining the ethyl ester at position 4 untouched. This building block has been incorporated into libraries of substituted pyrrole-2-carboxamides screened against kinase targets; published data for this specific configuration is limited, but exemplary results from an internal collaboration (data on file, Report No. AMC-2024-PEC-112) demonstrate IC₅₀ values in the 200–800 nM range against EGFR T790M mutant kinase for certain benzylamide derivatives. The presence of the 4-ethoxycarbonyl group serves not only as a masked acid but also as an electron-withdrawing substituent that modulates the pyrrole NH acidity (pKa ~13.2 in DMSO), facilitating N-alkylation under mild conditions (cesium carbonate, alkyl bromide, DMF, 60°C) with 85% conversion.

    Handling considerations and incompatibility with organometallic nucleophiles

    Unlike the corresponding N-methyl or N-Boc pyrroles, PEC-DM-401 retains a free N-H proton, which can be deprotonated by strongly basic reagents. Exposure to Grignard reagents (e.g., MeMgBr in THF) leads to immediate deprotonation and formation of an insoluble magnesium pyrrolide salt; this salt can subsequently undergo nucleophilic attack at the 4-ethoxycarbonyl group, yielding ketone byproducts. Consequently, synthetic sequences requiring organometallic additions must be performed after N-protection or after complete deprotection of both esters. The compound is classified as a non-dangerous good for transportation under 49 CFR 173.22, though local EH&S assessments recommend storage in a dry, nitrogen-inerted flammable-materials cabinet at 2–8°C to prolong shelf life beyond the specified retest date of 24 months from date of manufacture. Pre-drying is not required when the container has been properly sealed under argon; however, if the container has been opened and exposed to ambient humidity (≥60% RH) for more than 30 minutes, drying under vacuum (1 mbar, 25°C, 4 h) is advised before use in moisture-sensitive coupling reactions.

    Regulatory and Supply Chain Conformity

    Compliance and Certification Matrix
    Standard/Regulation Status Certificate Type
    REACH (EC) 1907/2006Pre-registered, tonnage band 1–10 t/aLetter of Access
    FDA 21 CFR Part 11 (electronic records for GMP batches)Applicable for GMP audited lots onlyAudit trail report
    ICH M7 (mutagenic impurities)Class 5 solvents only; no structural alerts for mutagenicity (TTC concept, Cramer class III)Q-SAR report
    ISO 9001:2015Manufacturing site certified (DE-123456-QM)Certificate on request
    Prop 65 (California)No listed substances presentStatement of compliance

    The product is manufactured under a 23-step controlled synthesis with six isolated intermediates. The final cGMP step involves a recrystallization from ethyl acetate/heptane (1:5 v/v) followed by drying in a vacuum tray dryer at 30°C for 8 h. Lot traceability is maintained from raw materials through to finished product via an electronic batch record system compliant with 21 CFR Part 11; each individual container bears a unique alphanumeric lot number linked to the master batch record, deviation reports, and QC analytical results. For buyers requiring regulatory starting material (RSM) designation, the internal policy defines the intermediate “4-ethoxycarbonyl-3,5-dimethylpyrrole-2-carboxylic acid” as the RSM, which means PEC-DM-401 is one step upstream of this definition and is therefore supplied as a late-stage advanced intermediate rather than a GMP-part-numbered API raw material. This distinction matters for the Drug Master File (DMF) strategy: the product is typically referenced in a Type II DMF under the general category of “pyrrole building block for API X,” with a letter of authorization issued to the holder of the IND or NDA.

    Comparability with N-Protected Analogs in Cross-Coupling Reactions

    The free N-H of PEC-DM-401 can either be a synthetic liability or an opportunity depending on the coupling partner. Suzuki-Miyaura cross-coupling at position 5 is not possible without N-protection due to competing N-H oxidative addition to palladium(0) catalysts. However, compared to N-Boc protected analogs (e.g., T-Butyl N-Boc-3,5-Dimethyl-4-Ethoxycarbonylpyrrole-2-Carboxylate), the unprotected pyrrole exhibits a 2.3 times faster rate of electrophilic aromatic substitution with N-chlorosuccinimide in THF at 0°C, as determined by ReactIR monitoring of the product peak at 1520 cm⁻¹. This is attributed to the absence of steric shielding by the Boc group. In practice, the free pyrrole can be chlorinated selectively at position 5 using 1.05 equivalents of NCS at −10°C in anhydrous DMF, achieving 94% regioselectivity; subsequent palladium-catalyzed coupling of the resulting 5-chloro intermediate with arylboronic acids proceeds in 66–82% yield when employing XPhos Pd G2 precatalyst (2 mol%) and K₃PO₄ in THF/water at 50°C. In the N-Boc series, the same sequence requires harsher conditions (80°C, 5 mol% catalyst) and results in partial cleavage of the Boc group, complicating purification. This exemplifies the strategic advantage of a free N-H with orthogonal ester protection: no additional deprotection step is needed after cross-coupling, while the esters remain intact for further transformations.

    For agrochemical discovery programs seeking pyrrole amides as potential fungicides, the tert-butyl ester also provides a lipophilic handle that can temporarily modulate log P without permanently installing a hydrophobic moiety. Transient protection allows the candidate molecule to be screened in cell-based assays, and if activity is confirmed, the tert-butyl group can be cleaved to reveal the free carboxylate for salt formation or to reduce lipophilicity. This iterative “protect-screen-deprotect” strategy has been applied successfully in lead optimization campaigns at several CROs, with PEC-DM-401 serving as the enabling building block. No patent restrictions encumber its use in commercial synthesis, as the composition of matter is part of the general chemical space for 3,5-dimethylpyrrole diesters first disclosed in the 1970s; thus freedom-to-operate assessments for derivative products are typically straightforward.

    High-Temperature Stability during Distillative Purification

    For customers employing fractional distillation to further purify the product before use in polymerizations (e.g., production of pyrrole-thiophene copolymers for organic electronics), thermal gravimetric analysis (TGA) shows an onset of decomposition at 195°C under nitrogen, with a 5% mass loss occurring at 210°C. Short-path distillation at 140–150°C (oil bath temperature, vacuum 0.05 mbar) yields a colorless distillate that solidifies upon cooling without detectable degradation, as assessed by HPLC purity remaining at 98.2%. The symmetrical diethyl ester analog decomposes exothermically at 185°C, likely via a retro-Diels-Alder-type fragmentation of the pyrrole ring. The enhanced stability of PEC-DM-401 is partially ascribed to the steric bulk of the tert-butyl group reducing intermolecular interactions that lead to dimerization and charring. This thermal margin, while modest, is sufficient to permit short-path molecular distillation as a final purification step in kilo-scale production, provided residence time in the heated zone does not exceed 3 minutes. Evaporator suppliers (e.g., BÜCHI, UIC) have verified that a thin-film evaporator with an internal condenser can handle the product without fouling over a 5 kg batch.

    When incorporated into polyvinyl chloride (PVC) formulations as a co-stabilizer precursor—where it is first hydrolyzed to the diacid and then transformed into a calcium or zinc salt—the compound exhibits no discoloration upon static heating at 180°C for 30 minutes in dioctyl phthalate plasticized PVC, as measured by yellowness index change (ΔYI) of less than 2.0 according to ASTM D1925-70. This performance characteristic, while not the primary application, is noted for customers exploring dual-use intermediates for both pharmaceutical and polymer applications.

    Variances between Pilot and Production Lots: A Co-crystal Former Analysis

    During process development, an unexpected batch-to-batch variation was traced to the formation of a transient co-crystal between PEC-DM-401 and the ethyl acetate solvate of a dimeric impurity. When the final recrystallization solvent was switched from ethyl acetate/heptane to isopropyl acetate/heptane, the co-crystal formation was completely suppressed, as confirmed by DSC and hot-stage microscopy. This finding was communicated to all customers receiving the product under the previous solvent system, and a recall of lot PEC-401-L023 was initiated voluntarily. Subsequent production has employed only isopropyl acetate in the final recrystallization step, with no recurrence of the issue in over 40 commercial lots. The manufacturing history demonstrates a robust process capable of delivering consistent quality, supported by statistical process control charts for the key attributes of assay and melting point.

    Stability data accumulated under ICH Q1A guidelines indicate that the product meets specifications after 36 months of storage at 5±3°C in the original sealed container. Forced degradation studies under oxidative conditions (exposure to air at 40°C/75% RH for 2 weeks) resulted in 3.2% degradation, primarily to the monoacid resulting from tert-butyl ester hydrolysis. The ethyl ester remained fully intact, which is consistent with the relative hydrolytic susceptibility of the two ester groupings and underscores the importance of storing the product under inert gas and within the temperature-controlled environment.